Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Human SCAMP1 (aa 1-17), Synthetic Peptide, Invitrogen™

Catalog No. PEP105
Click to view available options
Quantity:
50 μg

Synthetic Peptide

Human SCAMP 1 (residues 1-17) Synthetic Peptide, PEP-105, from Invitrogen.

PEP-105 is a 17 amino acid synthetic peptide whose sequence corresponds to amino acid residues 1-17 of human SCAMP 1. The sequence of this peptide is (amino to carboxy terminus): M (1)-S-D-F-D-S-N-P-F-A-D-P-D-L-N-N-P (17)-CThis peptide may be used for neutralization and control experiments with the polyclonal antibody that reacts with this product and human SCAMP 1, catalog # PA1-739. Using a solution of peptide of equal volume and concentration to the corresponding antibody will yield a large molar excess of peptide (∼70-fold) for competitive inhibition of antibody-protein binding reactions.Reconstitute with 0.1 ml of distilled water.
TRUSTED_SUSTAINABILITY

Specifications

Gene ID (Entrez) 9522
Species Human
Purification Method purified
Accession Number O15126
Common Name Human SCAMP1 (aa 1-17)
Concentration 0.5 mg/mL
Content And Storage -20°C. Avoid freeze-thaw cycles.
Description Synthetic Peptide
Format Lyophilized
Formulation peptide with no preservative
For Use With (Application) Control
Gene Symbol SCAMP1
Lyophilized Yes
Preservative No preservative
Product Type Peptide
Quantity 50 μg
Regulatory Status RUO - research use only
Sequence M(1)-S-D-F-D-S-N-P-F-A-D-P-D-L-N-N-P(17)-C
Show More Show Less
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.